Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma
Our study proposes a dual-targeted therapeutic strategy for HCC, which may represent a promising treatment approach.
Authors
- Tianmei Fu
- Yuankang Xie (ORCID: https://orcid.org/0000-0001-5374-4626)
- Zhaohong Mo
- Yingliang Li (ORCID: https://orcid.org/0000-0001-8272-0092)
- Aiping Le (ORCID: https://orcid.org/0000-0003-3867-6578)
- Kang Fang (ORCID: https://orcid.org/0000-0002-8233-1182)
- Yin Fang (ORCID: https://orcid.org/0000-0002-7068-1628)
- Boxuan Zhou (ORCID: https://orcid.org/0000-0002-1103-0059)
- Yangyang Fang
- Kuai Yu (ORCID: https://orcid.org/0000-0001-9699-4780)
- Ziqing Xiong
- Yu Wang (ORCID: https://orcid.org/0000-0003-2420-3585)
- Wei Liu (ORCID: https://orcid.org/0000-0003-2018-7004)
Institutions
- Nanchang University (CN)
- Guangxi Medical University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ijn.s498065
- Citations
- 2
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.57